Family-Based Substance Use Prevention for Youth at Risk
Trial Summary
What is the purpose of this trial?
Risk for substance use disorder (SUD) begins early in the life course. Although preventing and decreasing illicit and nonmedical drug use among youth is an urgent public health priority, there are currently few evidence-based prevention strategies feasible for delivery in the primary care setting. The investigators propose a three-year plan to collect critical pilot data to pilot test and optimize a dyadic intervention that aims to increase family resilience, strengthen coping skills, help families plan for the future, and prevent youth SUD. The 'prototype' for the intervention approach is Family Talk, an evidence-based parent-youth dyadic intervention that can be delivered within the existing infrastructure of the patient-centered medical home. The investigators have made preliminary adaptations to the model in preparation for testing. To prepare for a subsequent efficacy study, a two-arm pilot randomized controlled trial of the intervention with 40 parent-youth dyads to optimize the intervention model will be conducted. The feasibility of the intervention will be evaluated. In addition, empiric estimates of study parameters to inform the planning of a fully powered randomized controlled trial and plausible intervention targets using semi-structured qualitative interviews will be obtained.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on family-based interventions rather than medication changes.
What data supports the effectiveness of the treatment Modified Family Talk Intervention for preventing substance use in youth at risk?
Research shows that family-based programs, like the Strengthening Families Program, can help prevent substance use in young people by focusing on building family strengths and skills. These programs are more effective when they involve both parents and children, and they have been shown to work in various settings, including healthcare.12345
Is the Family-Based Substance Use Prevention for Youth at Risk treatment safe for humans?
The research on family-based substance use prevention programs, including those similar to the Family Talk Intervention, generally focuses on their effectiveness rather than safety. However, these programs are typically designed to be safe as they involve family education and support rather than medical or pharmaceutical interventions.13467
How is the Modified Family Talk Intervention different from other treatments for preventing substance use in youth?
The Modified Family Talk Intervention is unique because it involves both youth and their families, focusing on improving family communication and relationships to prevent substance use, unlike many other programs that primarily target parents. This approach emphasizes the role of family dynamics in building resilience against substance use.13589
Research Team
Caroline J Kistin, MD MSc
Principal Investigator
Brown University School of Public Health
Eligibility Criteria
This trial is for youth aged 12-18 without substance use disorders, who are comfortable in English or Spanish. Their parents must be over 18, receiving treatment for SUD and getting primary care at Boston Medical Center Health System.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention Refinement
20 parent-youth dyads will receive the Modified Family Talk intervention to optimize the intervention model
Parameter Estimation
20 parent-youth dyads will receive current best practice care to estimate study parameters for future trials
Follow-up
Participants are monitored for safety and effectiveness after the intervention
Treatment Details
Interventions
- Modified Family Talk Intervention
- Parameter Estimation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brown University
Lead Sponsor
Boston Medical Center
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
National Institutes of Health (NIH)
Collaborator
National Institute of Drug Abuse
Collaborator